anmelden
OMX Nordic 40
2.616,70
PKT
+0,46
PKT
+0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.09.17 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 12.09.17 | Volvo (B) Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Neutral | UBS AG | |
| 11.09.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.09.17 | AstraZeneca Neutral | BNP PARIBAS | |
| 11.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 11.09.17 | AstraZeneca buy | Deutsche Bank AG | |
| 11.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 11.09.17 | AstraZeneca Neutral | Credit Suisse Group | |
| 11.09.17 | AstraZeneca Reduce | HSBC | |
| 11.09.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 08.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 07.09.17 | Nokia overweight | Barclays Capital | |
| 07.09.17 | ABB (Asea Brown Boveri) Sell | Citigroup Corp. | |
| 07.09.17 | AstraZeneca buy | Citigroup Corp. | |
| 07.09.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 07.09.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 06.09.17 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
| 06.09.17 | Nokia buy | Goldman Sachs Group Inc. | |
| 05.09.17 | AstraZeneca buy | Deutsche Bank AG | |
| 01.09.17 | Volvo (B) buy | Citigroup Corp. | |
| 01.09.17 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 31.08.17 | AstraZeneca Neutral | UBS AG | |
| 30.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.08.17 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 24.08.17 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.08.17 | Nokia kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 18.08.17 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 18.08.17 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 17.08.17 | Novo Nordisk buy | UBS AG | |
| 17.08.17 | Novo Nordisk Reduce | HSBC | |
| 17.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 15.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 11.08.17 | Novo Nordisk Neutral | Citigroup Corp. | |
| 10.08.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 10.08.17 | Novo Nordisk buy | UBS AG | |
| 10.08.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 10.08.17 | Novo Nordisk Underweight | Barclays Capital | |
| 10.08.17 | Novo Nordisk buy | Goldman Sachs Group Inc. |